By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


TrovaGene, Inc. 

420 Lexington Avenue
Suite 170
New York  New York  10170  U.S.A.
Phone: n/a Fax: n/a



Company News
Clinical Data For TrovaGene, Inc.'s Precision Cancer Monitoring Platform Presented At The European Cancer Congress 9/25/2015 10:44:39 AM
Results from Second Large-Scale Clinical Trial For TrovaGene, Inc.'s Urine-based HPV Test Released 9/21/2015 11:58:45 AM
TrovaGene, Inc. Forms European Institute With Alberto Bardelli, Ph.D.; Core Technologies Transferred From University Of Torino 9/10/2015 6:38:53 AM
TrovaGene, Inc.'s Urine-Based Liquid Biopsy Platform Shown To Detect Impact Of Cancer Therapy Within 24 Hours 9/9/2015 6:35:15 AM
TrovaGene, Inc. To Present Clinical Data And Capabilities Of Its Urine-Based Liquid Biopsy Platform At The 7th Annual Next Generation Dx Summit 8/18/2015 6:46:23 AM
TrovaGene, Inc. Announces Second Quarter 2015 Financial Results 8/11/2015 10:05:32 AM
TrovaGene, Inc. Schedules Release Of Second Quarter 2015 Financial Results And Investor Conference Call 7/23/2015 11:59:50 AM
TrovaGene, Inc. Announces Closing Of Public Offering Of Common Stock 7/22/2015 10:07:40 AM
TrovaGene, Inc. Announces Public Offering Of Common Stock 7/17/2015 6:36:04 AM
TrovaGene, Inc. Initiates Study to Monitor Response to Immunotherapy in Melanoma Patients Using its Precision Cancer Monitoring Platform 7/8/2015 6:39:30 AM